Document o9yENdY2OLwG0xBjRyNjN7J5r

To: Clegg, Patsy M SCC-CHSE-PC <patsy.clegg@shell.com> From: OttoWong@aol.com <OttoWong@aol.com> Cc: jennifer. b.galvin@conocophillips.com <jennifer. b.galvin@conocophillips.com>; Cagen, Stuart Z SCC-CF-SS <stuart.cagen@shell.com>; Tsai, Shan P SHLOIL-SHS <Shan.Tsai@shell.com>; jarnotb@api.org <jarnotb@api.org> Bcc: Received Date: 2005-07-01 00:46:36 GMT Subject: Email from Technical Committee to Principal Investigators Dear Patsy: Shan Tsai forwarded to me your email to the Pis (below). Although my name appeared on the receivers' list, I never received the email directly from you. I could not tell from your email what address you used. To ensure that I get your email in the future, please use the following addresses: ottowong@aol.com ottowong@shmu.edu.cn Regards, Otto ******** Otto Wong, Sc.D., FAC.E. Fellow, American College of Epidemiology Chief Epidemiologist, Applied Health Sciences, San Mateo, California, USA Adjunct Professor of Epidemiology, Tulane University, New Orleans, USA Adjunct Professor of Community Medicine, Chinese University of Hong Kong Honorary Professor of Community Medicine, University of Hong Kong Visiting Professor of Occupational Epidemiology, Fudan University, Shanghai Associate Editor, Annals of Epidemiology Associate Editor, Occupational and Environmental Medicine Editorial Board, Regulatory Toxicology and Pharmacology Tel: 1 (650) 347-7898 Fax: 1 (650) 344-6887 Email: OttoWong@aol.com From: Clegg, Patsy M SCC-CHSE-PC Sent: Wednesday, June 29,20059:26 AM To: Fu (E-mail); Richard Irons (E-mail); Otto Wong (E-mail) Cc: You-xin Liang (E-mail); Rob Schnatter (E-mail); Tom Armstrong (E-mail); Yimei Zhou (E-mail); Gary R. Krieger (E-mail) Subject: Shanghai Health Study - Communication from the Benzene Health Research Consortium Dear Dr. Fu, Dr. Irons, Dr. Wong; The Benzene Health Research Consortium (BHRC) wishes to reaffirm that the Shanghai Health Study is a completely independent study under the direction of the principal investigators. We reaffirm that a grant to the University of Colorado and contracts with Fudan University and Applied Health Sciences have been awarded to the principal investigators to fund these studies. Dr. Richard Irons, the principal investigator from the University of Colorado, is responsible for the clinical, laboratory, and exposure assessment portions of the study. He has contracted with EMBSI to do the exposure SH ELL-MCCLU RG-057804 assessment. Activities in support of the exposure assessment, such as an exposure assessment workshop, is the responsibility of Dr. Irons. The consortium appreciates the excellent work that has been done and the work that is continuing. We look forward to your updates at the annual meeting in November. Regards, Patsy Clegg Jennifer Galvin Patsy Clegg Jennifer Galvin Chair, Oversight Committee, BHRC Chair, Technical Committee, BHRC Shell Chemical LP ConocoPhillips Tel: ? 713 241 2521 Fax: ? 713 241 3325 Email: patsy.clegg@shell.com Tel:: ?918-661-3865 Fax: ?918-662-1139 Email: jennifer.b.galvin@conocophillips.com SH ELL-MCCLU RG-057805